GenVault Corp.

GenVault Corp. specializes in biorepository services, providing secure and compliant storage solutions for biological samples, essential for clients in life sciences and biopharmaceutical sectors. Established in 2001, GenVault Corp. is based in Carlsbad, US.

The company focuses on biorepository services for biological samples. In February 2011, GenVault was acquired by IntegenX Inc. , a portfolio company of various investors. The firm has completed 10 deals, with its latest funding round being a VENTURE DEBT round amounting to USD 6.

80 mn, contributing to a total of USD 13. 00 mn raised to date. The founder, Michael Lebbin, possesses a history of entrepreneurial ventures. GenVault specializes in biorepository services designed to ensure the secure and compliant storage of biological samples.

Their core offerings encompass temperature-controlled storage solutions, including ambient, cold, frozen, and cryogenic environments, all engineered to preserve the integrity of biospecimens, biological materials, and high-value equipment. GenVault's services are critical for clients in the life sciences, clinical research, and biopharmaceutical sectors, addressing the need for reliable and compliant sample management. The company's facility, located in West Deptford, NJ, is equipped with advanced technology ensuring operational integrity across diverse storage conditions. Target markets for GenVault's services include academic institutions, pharmaceutical companies, and biotechnology firms, primarily in North America and Europe, which require compliance with stringent regulatory standards.

GenVault operates a business model focused on B2B transactions, providing tailored storage and transportation services to its clients in the life sciences and biopharmaceutical industries. Revenue is generated through contracts for sample storage solutions, lab relocation services, and specialized transport of temperature-sensitive biological materials. The typical transaction structure may involve subscription agreements, where clients secure long-term storage services, as well as one-time fees for lab relocation and transport services. For instance, a client might engage GenVault for the secure storage of 50,000 samples under a multi-year contract, which includes detailed service agreements ensuring compliance and security.

While specific pricing plans are not disclosed, GenVault emphasizes transparent pricing structures that support long-term client relationships while ensuring predictable budgeting for their partners. GenVault Corp. plans to expand its offerings and geographic reach significantly. Though specific upcoming products have not been detailed, the company is focusing on enhancing its biorepository technologies.

Market expansion is targeted towards Europe and Asian regions by 2015, leveraging its existing technology and expertise. The recent funding of USD 6. 80 mn will support these initiatives, enabling the firm to enhance its facility capabilities and explore new market strategies.